Merck Millipore + Sigma-Aldrich = Merck’s life science business. Operating in the U.S. and Canada as MilliporeSigma
In late 2015, Merck Millipore joined forces with Sigma-Aldrich. Our combined organization, which operates as MilliporeSigma in the United States and Canada, is the life science business of Merck – and a global leader in the $125 billion life science industry.
Our shared purpose is to solve the toughest problems in life science by collaborating with the global scientific community. Together, we offer a broad portfolio of more than 300,000 products, including many of the most highly respected brands in the industry. Our offerings span every step of the biotech/biopharma production chain, creating a complete end-to-end workflow with enhanced customer service, a simplified interface and a leading e-commerce and distribution platform.
Merck’s life science business operates 65 manufacturing sites worldwide and employs more than 19,000 people in 66 countries. This geographic reach, combined with our innovative portfolio, industry-leading capabilities, and a culture that fosters curiosity and collaboration, uniquely positions us to anticipate and fulfill our customers’ needs – and solve their toughest life science problems.
ALBIOGEN Company Limited is a young, actively growing company, specializing on providing the whole range of services, dedicated to Illumina products promotion, customer support and customer service.
− Our team consists of highest-level specialists, having extensive experience in sales and marketing, knowledge in sequencing instruments, and network to deliver a faster turnaround time, improved customer experience and user-friendly ordering process.
− We are proud to provide our customers the highest level of logistics, which allows us to supply our products to the end-user carefully and within a shortest period of time.
Illumina Inc. (San Diego, USA) is innovative, rapidly growing company, transforming human health as the global leader in sequencing and array-based technologies. The company serves customers in a broad range of markets, enabling the adoption of genomic solutions in research and clinical settings. Illumina sequencing platforms allows to carry out genetic research for science, medicine, agriculture, veterinary and criminalistics.
Albiogen activity is focused on making NGS and Biochip technologies more available on the territory of Russian Federation and CIS countries.
ALBIOGEN Company Limited is the sole official Illumina distributor on the territory of Russian Federation, Republic of Belarus and Kazakhstan.
Our main task is providing our customers a complete access to the advanced Illumina technologies and services, including sequencing and array-based platforms and the whole specter of reagents.
We will be happy to discuss your individual wishes to participate and see you as a business partner!
For more information you can contact us by phone or email.